TY  - RPRT
TI  - Optimal maintenance dose immunotherapy based on major allergen content or potency labeling.
AU  - H Nolte
PY  - 1998
DO  - 10.1111/j.1398-9995.1998.tb03781.x
UR  - https://pubmed.ncbi.nlm.nih.gov/9491237/
ID  - 9491237
ER  -